LESLIE FINCHER: Open Payments
NPI 1073980512 · CLINTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,388 in 26 payments from 9 companies in 2025. Trend: 2023 $415 · 2024 $5,808 · 2025 $4,388
Speaker / faculty: $3,000Travel & lodging: $800Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| Optinose US, Inc. | 12 | $4,053 |
| GENZYME CORPORATION | 2 | $78 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 2 | $56 |
| ALK-Abello, Inc | 2 | $46 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: Xhance, DUPIXENT, NUCALA, TEZSPIRE, NEFFY, TIMOTHY, STANDARDIZED, Rhapsido.
Industry payments across MD — which companies pay providers there.
